Skip to main content
. 2004 Nov;78(22):12489–12496. doi: 10.1128/JVI.78.22.12489-12496.2004

FIG. 3.

FIG. 3.

Inhibition of DsRed-VLP2/6 and GFP-VLP2/6/7 binding by anti-human Fab′2 Abs. Enriched B-cell PBMC were incubated with increasing concentrations of polyclonal Abs directed to human Fab′2 and with DsRed-VLP2/6 in samples from adults (A) and neonates (B) or with GFP-VLP2/6/7 in samples from adults (C). Goat polyclonal Abs to murine μ chain Abs were used as a control. The results are expressed as the percentages of residual binding of the corresponding fluorescent VLP to CD19pos cells.